Review



jc 1 kit  (Beyotime)


Bioz Verified Symbol Beyotime is a verified supplier
Bioz Manufacturer Symbol Beyotime manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Beyotime jc 1 kit
    Jc 1 Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 15127 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13084373-92-7-10
    Average 99 stars, based on 15127 article reviews
    jc 1 kit - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Fluorescence:

    Article Title: CD8 + T Cells in Association with SCD1 Regulate Cervical Cancer and Tumour Microenvironment Correlation Research.
    Article Snippet: Cells were then incubated with 5 μM DCFH-DA (S0033s, Beyotime) or 5 μM FerroOrange (M36008, Thermo Fisher Scientific) in HBSS for the detection of ROS, Fe2+ (F374,Dojindo), respectively. .. MMP was determined by incubating cells with 2 μM JC-1 (C2003S, Beyotime) fluorescent probe, which yields green fluorescence at low concentrations while lights up in red when it accumulates in the mitochondria at high concentrations. ..

    Incubation:

    Article Title: Leucovorin enhances curcumin-induced inhibition of cell viability and ferroptosis in colorectal cancer cells
    Article Snippet: Images were captured using an inverted fluorescence microscope (Motic Incorporation, Ltd.). .. To assess MMP, CRC cells were incubated with MMP Assay Kit with JC-1 (cat. no. C2006; Beyotime Institute of Biotechnology) for 24 h. The JC-1 working solution was prepared according to the manufacturer's instructions. ..

    Mmp Assay:

    Article Title: Leucovorin enhances curcumin-induced inhibition of cell viability and ferroptosis in colorectal cancer cells
    Article Snippet: Images were captured using an inverted fluorescence microscope (Motic Incorporation, Ltd.). .. To assess MMP, CRC cells were incubated with MMP Assay Kit with JC-1 (cat. no. C2006; Beyotime Institute of Biotechnology) for 24 h. The JC-1 working solution was prepared according to the manufacturer's instructions. ..

    Article Title: VSNL1 attenuates hypoxia-induced myocardial apoptosis by regulating the CNP/NPRB pathway
    Article Snippet: .. The MMP was evaluated using the Enhanced MMP Assay Kit with JC-1 (Beyotime Institute of Biotechnology). ..

    CCK-8 Assay:

    Article Title: Polygonatum sibiricum polysaccharides ameliorate diabetes-induced vascular endothelial injury partly through Nrf2/GPX4 activation
    Article Snippet: Fetal bovine serum (FBS, CAT#SA211.01) and Dulbecco's Modified Eagle Medium (DMEM, CAT#CGM102.05) were sourced from Cellmax (Beijing, China). .. The Cell Counting Kit-8 (CCK-8, CAT#C0037), bicinchoninic acid (BCA, CAT#P0012S), penicillin-streptomycin (CAT#C0222), MDA (CAT#S0131S), DAPI (CAT#C1006), and JC-1 (CATC2003S) were obtained from Beyotime (Shanghai, China). .. Assay kits for LDL (CAT#A113-1-1), HDL (CAT#A112-2-1), and triglycerides (TG, CAT#A110-2-1) were procured from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).

    Article Title: ROS-responsive hydrogels functionalized with Cu/Zn MOF targeting oxidative stress mitigation and inflammation modulation to promote spinal cord injury repair
    Article Snippet: Zinc nitrate hexahydrate (98%, Zn(NO 3 ) 2 ·6H 2 O), copper nitrate trihydrate (98%, Cu(NO 3 ) 2 ·3H 2 O), 2-Methylimidazole (99%), L-glutathione reduced (≥98.0%), chitosan solution (QCS), tannic acid (TA), sodium bicarbonate (NaHCO 3 ), lipopolysaccharide (LPS), Methylene blue, Rhodamine B, 2,2-Diphenyl-1-picrylhydrazyl (DPPH), Collagenase type I, and 2,2′-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) were purchased from Sigma Aldrich Co. Ltd. Methanol, hydrogen peroxide, and ethanol were purchased from Macklin. .. Dichlorodihydrofluorescein diacetate kit (DCFH-DA), Dihydroethidium kit (DHE), CCK-8 Kit, Calcein/PI cell viability/cytotoxicity assay kit, Nitroblue tetrazolium (NBT), Enhanced mitochondrial membrane potential assay kit with JC-1, Mitochondrial Superoxide Assay Kit with MitoSOTM Red, and Luxol fast blue (LFB) were purchased from Shanghai Beyotime Biotechnology Co., Ltd. Dulbecco's modified eagle medium (DMEM), Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12), Poly-D-lysine (PDL), Neurobasal-A medium (NB), B-27 Serum-Free Supplement (B-27), Hank's balanced salt solution (HBSS), Trypsin, fetal bovine serum (FBS) and phosphate buffer solution (PBS) were obtained from Gibco. ..

    Multiple Displacement Amplification:

    Article Title: Polygonatum sibiricum polysaccharides ameliorate diabetes-induced vascular endothelial injury partly through Nrf2/GPX4 activation
    Article Snippet: Fetal bovine serum (FBS, CAT#SA211.01) and Dulbecco's Modified Eagle Medium (DMEM, CAT#CGM102.05) were sourced from Cellmax (Beijing, China). .. The Cell Counting Kit-8 (CCK-8, CAT#C0037), bicinchoninic acid (BCA, CAT#P0012S), penicillin-streptomycin (CAT#C0222), MDA (CAT#S0131S), DAPI (CAT#C1006), and JC-1 (CATC2003S) were obtained from Beyotime (Shanghai, China). .. Assay kits for LDL (CAT#A113-1-1), HDL (CAT#A112-2-1), and triglycerides (TG, CAT#A110-2-1) were procured from Nanjing Jiancheng Bioengineering Institute (Nanjing, China).

    Staining:

    Article Title: FAP-targeting peptide-directed nanoprobes enable tumor microenvironment-activatable MR/NIRF imaging of breast cancer primary tumor and lung metastases
    Article Snippet: .. Following this, the cells were stained using the enhanced mitochondrial membrane potential assay kit with JC-1 (Beyotime Ltd, China) according to the manufacturer's instructions. .. Finally, the cells were observed under a fluorescence microscope (OLYMPUS, Japan).

    Article Title: IL-37/IL-1R8 blocks keratinocyte acantholysis via suppressing ADAM17/EGFR
    Article Snippet: .. The cells were then stained with 1.0 mM of JC-1 (cat. no. C2005; Beyotime Biotechnology) at 37°C for 10 min. ..

    Membrane:

    Article Title: FAP-targeting peptide-directed nanoprobes enable tumor microenvironment-activatable MR/NIRF imaging of breast cancer primary tumor and lung metastases
    Article Snippet: .. Following this, the cells were stained using the enhanced mitochondrial membrane potential assay kit with JC-1 (Beyotime Ltd, China) according to the manufacturer's instructions. .. Finally, the cells were observed under a fluorescence microscope (OLYMPUS, Japan).

    Article Title: ROS-responsive hydrogels functionalized with Cu/Zn MOF targeting oxidative stress mitigation and inflammation modulation to promote spinal cord injury repair
    Article Snippet: Zinc nitrate hexahydrate (98%, Zn(NO 3 ) 2 ·6H 2 O), copper nitrate trihydrate (98%, Cu(NO 3 ) 2 ·3H 2 O), 2-Methylimidazole (99%), L-glutathione reduced (≥98.0%), chitosan solution (QCS), tannic acid (TA), sodium bicarbonate (NaHCO 3 ), lipopolysaccharide (LPS), Methylene blue, Rhodamine B, 2,2-Diphenyl-1-picrylhydrazyl (DPPH), Collagenase type I, and 2,2′-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) were purchased from Sigma Aldrich Co. Ltd. Methanol, hydrogen peroxide, and ethanol were purchased from Macklin. .. Dichlorodihydrofluorescein diacetate kit (DCFH-DA), Dihydroethidium kit (DHE), CCK-8 Kit, Calcein/PI cell viability/cytotoxicity assay kit, Nitroblue tetrazolium (NBT), Enhanced mitochondrial membrane potential assay kit with JC-1, Mitochondrial Superoxide Assay Kit with MitoSOTM Red, and Luxol fast blue (LFB) were purchased from Shanghai Beyotime Biotechnology Co., Ltd. Dulbecco's modified eagle medium (DMEM), Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12), Poly-D-lysine (PDL), Neurobasal-A medium (NB), B-27 Serum-Free Supplement (B-27), Hank's balanced salt solution (HBSS), Trypsin, fetal bovine serum (FBS) and phosphate buffer solution (PBS) were obtained from Gibco. ..

    Immunoprecipitation:

    Article Title: Exosomal miR-145-5p from BMSCs alleviates AKI-induced renal fibrosis via KLHL12/KHSRP-mediated m6A-dependent repression of FLI-1.
    Article Snippet: .. 2.1Reagents and antibodies Immunoprecipitation assay kit(P2195S), ROS (S0033M), JC-1 (C2006), and Tunel (C1088) assay kits were supplied by Beyotime Biotechnology. .. Lentiviral vectors (miR-145-5p, miR-145-IN, siKLHL12, OE-KHSRP, siKHSRP, siFLI-1, and negative controls) were sourced from Shanghai Yuanke Biotechnology Co., LTD. Thermo Fisher Scientific was the supplier of CellTrackerTM CM-DiI (C7000).

    TUNEL Assay:

    Article Title: Exosomal miR-145-5p from BMSCs alleviates AKI-induced renal fibrosis via KLHL12/KHSRP-mediated m6A-dependent repression of FLI-1.
    Article Snippet: .. 2.1Reagents and antibodies Immunoprecipitation assay kit(P2195S), ROS (S0033M), JC-1 (C2006), and Tunel (C1088) assay kits were supplied by Beyotime Biotechnology. .. Lentiviral vectors (miR-145-5p, miR-145-IN, siKLHL12, OE-KHSRP, siKHSRP, siFLI-1, and negative controls) were sourced from Shanghai Yuanke Biotechnology Co., LTD. Thermo Fisher Scientific was the supplier of CellTrackerTM CM-DiI (C7000).

    Modification:

    Article Title: ROS-responsive hydrogels functionalized with Cu/Zn MOF targeting oxidative stress mitigation and inflammation modulation to promote spinal cord injury repair
    Article Snippet: Zinc nitrate hexahydrate (98%, Zn(NO 3 ) 2 ·6H 2 O), copper nitrate trihydrate (98%, Cu(NO 3 ) 2 ·3H 2 O), 2-Methylimidazole (99%), L-glutathione reduced (≥98.0%), chitosan solution (QCS), tannic acid (TA), sodium bicarbonate (NaHCO 3 ), lipopolysaccharide (LPS), Methylene blue, Rhodamine B, 2,2-Diphenyl-1-picrylhydrazyl (DPPH), Collagenase type I, and 2,2′-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) were purchased from Sigma Aldrich Co. Ltd. Methanol, hydrogen peroxide, and ethanol were purchased from Macklin. .. Dichlorodihydrofluorescein diacetate kit (DCFH-DA), Dihydroethidium kit (DHE), CCK-8 Kit, Calcein/PI cell viability/cytotoxicity assay kit, Nitroblue tetrazolium (NBT), Enhanced mitochondrial membrane potential assay kit with JC-1, Mitochondrial Superoxide Assay Kit with MitoSOTM Red, and Luxol fast blue (LFB) were purchased from Shanghai Beyotime Biotechnology Co., Ltd. Dulbecco's modified eagle medium (DMEM), Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12), Poly-D-lysine (PDL), Neurobasal-A medium (NB), B-27 Serum-Free Supplement (B-27), Hank's balanced salt solution (HBSS), Trypsin, fetal bovine serum (FBS) and phosphate buffer solution (PBS) were obtained from Gibco. ..



    Similar Products

    99
    MedChemExpress fluorescent probe jc 1
    Berberine (BBR)/nitidine chloride (NC) self‐assembled nanoparticles (BBR/NC‐SAPs) display potent and selective anti‐myeloma activity by inhibiting proliferation, clonogenicity, DNA synthesis, and inducing mitochondrial dysfunction. (A) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of free BBR and NC combination (1:1). (B) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. (C) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Colony formation assay demonstrating the potent, dose‐dependent inhibition of clonogenic survival. (D) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Analysis of DNA synthesis by EdU incorporation assay utilizing flow cytometry. The percentage of EdU‐positive (green) cells decreased in a dose‐dependent manner upon treatment. (E) Assessment of mitochondrial membrane potential <t>by</t> <t>JC‐1</t> staining employing flow cytometry. Treatment with BBR/NC‐SAPs induced a dose‐dependent loss of mitochondrial membrane potential. Data are presented as the mean ± SD from three independent experiments. Statistical significance was determined by a one‐way ANOVA followed by Dunnett's multiple comparison test versus the control group. * p < 0.05, ** p < 0.01.
    Fluorescent Probe Jc 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13483133-262-9-12
    Average 99 stars, based on 1 article reviews
    fluorescent probe jc 1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress probe
    Berberine (BBR)/nitidine chloride (NC) self‐assembled nanoparticles (BBR/NC‐SAPs) display potent and selective anti‐myeloma activity by inhibiting proliferation, clonogenicity, DNA synthesis, and inducing mitochondrial dysfunction. (A) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of free BBR and NC combination (1:1). (B) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. (C) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Colony formation assay demonstrating the potent, dose‐dependent inhibition of clonogenic survival. (D) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Analysis of DNA synthesis by EdU incorporation assay utilizing flow cytometry. The percentage of EdU‐positive (green) cells decreased in a dose‐dependent manner upon treatment. (E) Assessment of mitochondrial membrane potential <t>by</t> <t>JC‐1</t> staining employing flow cytometry. Treatment with BBR/NC‐SAPs induced a dose‐dependent loss of mitochondrial membrane potential. Data are presented as the mean ± SD from three independent experiments. Statistical significance was determined by a one‐way ANOVA followed by Dunnett's multiple comparison test versus the control group. * p < 0.05, ** p < 0.01.
    Probe, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13482932-249-9-10
    Average 99 stars, based on 1 article reviews
    probe - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress jc 1
    Gpat4 deficiency drives tumor-cell innate immune activation through the mtDNA-cGAS-dependent axis independently of the canonical cataly tic motif. (A) Schematic of glycerolipid and ether-lipid biosynthetic pathways highlighting GPAT4 and related enzymes used for comparison. (B) qPCR analysis of Ifnb1 , Ifi44 and Cxcl10 after depletion of the indicated lipid-metabolic regulators. (C) Domain organization of wild-type GPAT4 and the HXXXXD catalytic-motif mutant used for rescue experiments. (D) qPCR analysis of interferon-responsive genes in Gpat4 -depleted cells reconstituted with empty vector, wild-type GPAT4 or catalytic-mutant GPAT4 to determine whether the immune phenotype depends on the canonical catalytic motif. (E) qPCR analysis of Ifi44 and Ifit1 in control and Gpat4 -depleted cells treated with vehicle or the cGAS inhibitor RU521 to test cGAS dependence. (F) Measurements of mitochondrial membrane potential and reactive oxygen species in control and Gpat4 -depleted cells. The corresponding gating workflow <t>for</t> <t>JC-1</t> and H 2 DCFDA analysis is shown in (G, H) Representative transmission electron micrographs showing mitochondrial ultrastructure in 4T1 control (gNC) and Gpat4 -deficient (g Gpat4 ) cells. Red arrows indicate mitochondria. White boxes in (G) denote the regions enlarged in (H). Compared with control cells, Gpat4 -deficient cells display evident mitochondrial abnormalities, including altered shape and disorganization of cristae. Scale bars: 1 μm (G) and 0.5 μm (H). (I) Quantification of cytosolic mtDNA amplicons shown in the panel, including mtCytb (1), mtCytb (2), mtDloop1, mtDloop2, mtDloop3 and mtND6, together with nuclear DNA Tert as a contamination control, in cytosolic fractions prepared from control and Gpat4 -depleted cells. Bars denote mean ± s.e.m., P values are indicated in the respective panels, and exact P values are shown where provided and otherwise significance is denoted as ns or by asterisks. The statistical methods are described in the Materials and methods section. ns, not significant; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.000 1.
    Jc 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13382030-295-22-23
    Average 99 stars, based on 1 article reviews
    jc 1 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress jc 1 assay kit
    IPA protects mBMSCs against H 2 O 2 -induced apoptotic injury. (A) Effects of IPA on mBMSC viability over 1, 2, and 3 days, as determined by the CCK-8 assay. (B) Effects of IPA pretreatment on mBMSC viability following H 2 O 2 exposure for 12, 24, and 48 h, as determined by the CCK-8 assay. (C) Live/dead staining of mBMSCs on day 1 using propidium iodide (dead cells) and Calcein-AM (live cells). (D) Quantification of the dead-cell ratio based on live/dead staining. (E) Mitochondrial membrane potential of H 2 O 2 -treated mBMSCs with or without IPA treatment for 1 day, assessed <t>by</t> <t>JC-1</t> staining. (F) Quantification of the red/green fluorescence ratio from JC-1 staining. All experiments were repeated at least three times. Data are presented as the mean ± SD. ** P<0.01 compared with the control group. IPA, indole-3-propionic acid; mBMSCs, mouse bone marrow stromal cells; CCK-8, Cell Counting Kit-8; ns, not significant.
    Jc 1 Assay Kit, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13252943-68-5-8
    Average 99 stars, based on 1 article reviews
    jc 1 assay kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime jc 1 kit
    IPA protects mBMSCs against H 2 O 2 -induced apoptotic injury. (A) Effects of IPA on mBMSC viability over 1, 2, and 3 days, as determined by the CCK-8 assay. (B) Effects of IPA pretreatment on mBMSC viability following H 2 O 2 exposure for 12, 24, and 48 h, as determined by the CCK-8 assay. (C) Live/dead staining of mBMSCs on day 1 using propidium iodide (dead cells) and Calcein-AM (live cells). (D) Quantification of the dead-cell ratio based on live/dead staining. (E) Mitochondrial membrane potential of H 2 O 2 -treated mBMSCs with or without IPA treatment for 1 day, assessed <t>by</t> <t>JC-1</t> staining. (F) Quantification of the red/green fluorescence ratio from JC-1 staining. All experiments were repeated at least three times. Data are presented as the mean ± SD. ** P<0.01 compared with the control group. IPA, indole-3-propionic acid; mBMSCs, mouse bone marrow stromal cells; CCK-8, Cell Counting Kit-8; ns, not significant.
    Jc 1 Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13084373-92-7-10
    Average 99 stars, based on 1 article reviews
    jc 1 kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime jc 1 staining
    Res-PD-L1@nmEVs Restores Mitochondrial Homeostasis and Improves Energy Metabolism BEAS-2B cells were pretreated with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs followed by H/R stimulation for subsequent analysis. (A) Representative immunofluorescence images showing the expression and localization of PINK1 (green) and the mitochondrial marker TOMM20 (red), indicating activation of mitophagy. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (B) Quantitative analysis of PINK1 fluorescence intensity. (C) Expression and localization of autophagy-related proteins LC3B and Beclin-1 detected by immunofluorescence. (D-E) Quantitative analysis of LC3B (D) and Beclin-1 (E) fluorescence intensity. (F) Mitochondrial membrane potential assessed <t>by</t> <t>JC-1</t> staining and flow cytometry. (G) Oxygen consumption rate (OCR) profiles of lung epithelial cells under different treatments. (H-K) Key mitochondrial respiration parameters: basal respiration (H), maximal respiration (I), proton leak (J), and ATP production (K). (L) Representative confocal microscopy images of mitochondria stained with MitoTracker (green) and lysosomes stained with LysoTracker (red), demonstrating mitochondrial-lysosomal colocalization. Scale bar: 5 μm ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.
    Jc 1 Staining, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13011060-431-8-11
    Average 99 stars, based on 1 article reviews
    jc 1 staining - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime jc 1 working solution
    Res-PD-L1@nmEVs Restores Mitochondrial Homeostasis and Improves Energy Metabolism BEAS-2B cells were pretreated with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs followed by H/R stimulation for subsequent analysis. (A) Representative immunofluorescence images showing the expression and localization of PINK1 (green) and the mitochondrial marker TOMM20 (red), indicating activation of mitophagy. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (B) Quantitative analysis of PINK1 fluorescence intensity. (C) Expression and localization of autophagy-related proteins LC3B and Beclin-1 detected by immunofluorescence. (D-E) Quantitative analysis of LC3B (D) and Beclin-1 (E) fluorescence intensity. (F) Mitochondrial membrane potential assessed <t>by</t> <t>JC-1</t> staining and flow cytometry. (G) Oxygen consumption rate (OCR) profiles of lung epithelial cells under different treatments. (H-K) Key mitochondrial respiration parameters: basal respiration (H), maximal respiration (I), proton leak (J), and ATP production (K). (L) Representative confocal microscopy images of mitochondria stained with MitoTracker (green) and lysosomes stained with LysoTracker (red), demonstrating mitochondrial-lysosomal colocalization. Scale bar: 5 μm ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.
    Jc 1 Working Solution, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc12969342-111-25-28
    Average 99 stars, based on 1 article reviews
    jc 1 working solution - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Biotium cd31 / pecam-1(jc/70a)
    Res-PD-L1@nmEVs Restores Mitochondrial Homeostasis and Improves Energy Metabolism BEAS-2B cells were pretreated with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs followed by H/R stimulation for subsequent analysis. (A) Representative immunofluorescence images showing the expression and localization of PINK1 (green) and the mitochondrial marker TOMM20 (red), indicating activation of mitophagy. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (B) Quantitative analysis of PINK1 fluorescence intensity. (C) Expression and localization of autophagy-related proteins LC3B and Beclin-1 detected by immunofluorescence. (D-E) Quantitative analysis of LC3B (D) and Beclin-1 (E) fluorescence intensity. (F) Mitochondrial membrane potential assessed <t>by</t> <t>JC-1</t> staining and flow cytometry. (G) Oxygen consumption rate (OCR) profiles of lung epithelial cells under different treatments. (H-K) Key mitochondrial respiration parameters: basal respiration (H), maximal respiration (I), proton leak (J), and ATP production (K). (L) Representative confocal microscopy images of mitochondria stained with MitoTracker (green) and lysosomes stained with LysoTracker (red), demonstrating mitochondrial-lysosomal colocalization. Scale bar: 5 μm ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.
    Cd31 / Pecam 1(jc/70a), supplied by Biotium, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/CD31+%2F+PECAM-1(JC%2F70A)/custom%40bnc040639-100%4042686898
    Average 99 stars, based on 1 article reviews
    cd31 / pecam-1(jc/70a) - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress tetrachloro
    Piroxicam alleviated mitochondrial oxidative stress and restored the mitochondrial function of HG-induced HaCaT cells. After 24 h of induction with HG (60 mM), HaCaT cells were treated with piroxicam (0, 1.2, 3.7, 11, 33, 100 nM) for 24 h. (A) The level of ROS within mitochondria was assessed using MitoSOX staining, and red fluorescence indicated mitochondrial superoxide (scale bar = 50 μm). (B) HaCaT cells were stained with JC-1 dye. Red fluorescence (JC-1 aggregates) indicated healthy mitochondria with a high MMP, while green fluorescence (JC-1 monomers) indicated mitochondrial membrane depolarization (scale bar = 50 μm). (C) The expression of mitochondrial respiratory chain complex proteins, including ATP5A1 (complex V), MT-CO2 (complex IV), UQCRC1 (complex III), SDHB (complex II), and NDUFB8 (complex I), of HaCaT cells was determined by Western blotting. (D) Quantitative analysis of protein levels of ATP5A1, MT-CO2, UQCRC1, SDHB, and NDUFB8 was performed. (E) The expression of mitochondrial dynamics-related proteins, including DRP1, MFN1, MFN2, and OPA1, was measured using Western blotting. (F) Quantitative analysis of protein levels of DRP1, MFN1, MFN2, and OPA1 was performed. (G) HaCaT cells were stained with MitoTracker and observed using a confocal microscope (scale bar = 10 μm). All data were presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 compared to the 0 nM group ( n = 3). Abbreviations: HG, high glucose; SD, standard deviation; ROS, reactive oxygen <t>species;</t> <t>JC-1,</t> <t>5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine</t> iodide; MMP, mitochondrial membrane potential; ATP5A1, ATP synthase F1 subunit alpha; MT-CO2, mitochondrial-encoded cytochrome c oxidase 2; UQCRC1, ubiquinol-cytochrome c reductase core protein 1; SDHB, succinate dehydrogenase complex iron-sulfur subunit B; NDUFB8, NADH: ubiquinone oxidoreductase subunit B8; DRP1, dynamin-related protein 1; MFN1, mitofusin 1; MFN2, mitofusin 2; OPA1, optic atrophy 1.
    Tetrachloro, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/jc+1/JC-1/pmc13448677-104-5-10
    Average 99 stars, based on 1 article reviews
    tetrachloro - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    Berberine (BBR)/nitidine chloride (NC) self‐assembled nanoparticles (BBR/NC‐SAPs) display potent and selective anti‐myeloma activity by inhibiting proliferation, clonogenicity, DNA synthesis, and inducing mitochondrial dysfunction. (A) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of free BBR and NC combination (1:1). (B) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. (C) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Colony formation assay demonstrating the potent, dose‐dependent inhibition of clonogenic survival. (D) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Analysis of DNA synthesis by EdU incorporation assay utilizing flow cytometry. The percentage of EdU‐positive (green) cells decreased in a dose‐dependent manner upon treatment. (E) Assessment of mitochondrial membrane potential by JC‐1 staining employing flow cytometry. Treatment with BBR/NC‐SAPs induced a dose‐dependent loss of mitochondrial membrane potential. Data are presented as the mean ± SD from three independent experiments. Statistical significance was determined by a one‐way ANOVA followed by Dunnett's multiple comparison test versus the control group. * p < 0.05, ** p < 0.01.

    Journal: Advanced Science

    Article Title: Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma

    doi: 10.1002/advs.77174

    Figure Lengend Snippet: Berberine (BBR)/nitidine chloride (NC) self‐assembled nanoparticles (BBR/NC‐SAPs) display potent and selective anti‐myeloma activity by inhibiting proliferation, clonogenicity, DNA synthesis, and inducing mitochondrial dysfunction. (A) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of free BBR and NC combination (1:1). (B) Multiple myeloma cells (sensitive: 8226, KMS‐11; bortezomib‐resistant: 8226‐BTZR, KMS‐11‐BTZR) and normal B cells (GM12878) were treated for 48 h with a concentration gradient (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. (C) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Colony formation assay demonstrating the potent, dose‐dependent inhibition of clonogenic survival. (D) Cells were treated with the indicated concentrations (0, 2, 4, 6, 8, and 10 µg/mL) of BBR/NC‐SAPs. Analysis of DNA synthesis by EdU incorporation assay utilizing flow cytometry. The percentage of EdU‐positive (green) cells decreased in a dose‐dependent manner upon treatment. (E) Assessment of mitochondrial membrane potential by JC‐1 staining employing flow cytometry. Treatment with BBR/NC‐SAPs induced a dose‐dependent loss of mitochondrial membrane potential. Data are presented as the mean ± SD from three independent experiments. Statistical significance was determined by a one‐way ANOVA followed by Dunnett's multiple comparison test versus the control group. * p < 0.05, ** p < 0.01.

    Article Snippet: The mitochondrial membrane potential (ΔΨm) was assessed utilizing the fluorescent probe JC‐1 (MCE, USA) according to the manufacturer's protocol.

    Techniques: Activity Assay, DNA Synthesis, Concentration Assay, Colony Assay, Inhibition, Flow Cytometry, Membrane, Staining, Comparison, Control

    NR2F2 is essential for berberine (BBR)/nitidine chloride (NC) self‐assembled nanoparticles (BBR/NC‐SAPs)‐induced ferroptosis in multiple myeloma (MM) cells. (A) Cytotoxicity assays showing that NR2F2‐knockout cells locked the survival threshold and abolished the dosage‐dependent cytotoxicity of BBR/NC‐SAPs as compared to the control. (B) Colony formation assays revealing that NR2F2 knockout preserves clonogenic potential after BBR/NC‐SAPs treatment. (C) Analysis of DNA synthesis by EdU incorporation assay utilizing flow cytometry, demonstrating that NR2F2 knockout preserves cell proliferation potential after BBR/NC‐SAPs treatment. (D) Assessment of mitochondrial membrane potential (ΔΨm) via JC‐1 or similar dye, denoting that NR2F2 deletion prevents membrane depolarization triggered by BBR/NC‐SAPs. (E) Quantification of intracellular Fe 2+ showing blocked iron accumulation in NR2F2‐deficient cells upon BBR/NC‐SAPs treatment. (F) Lipid ROS levels measured by flow cytometry demonstrating that BBR/NC‐SAPs fail to elevate lipid peroxidation in NR2F2‐knockout cells. Ferroptosis‐related protein levels measured by western blot showing that BBR/NC‐SAPs fail to elevate lipid peroxidation in NR2F2‐knockout cells (G, 8226 and 8226‐BTZR; H, KMS‐11 and KMS‐11‐BTZR).

    Journal: Advanced Science

    Article Title: Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma

    doi: 10.1002/advs.77174

    Figure Lengend Snippet: NR2F2 is essential for berberine (BBR)/nitidine chloride (NC) self‐assembled nanoparticles (BBR/NC‐SAPs)‐induced ferroptosis in multiple myeloma (MM) cells. (A) Cytotoxicity assays showing that NR2F2‐knockout cells locked the survival threshold and abolished the dosage‐dependent cytotoxicity of BBR/NC‐SAPs as compared to the control. (B) Colony formation assays revealing that NR2F2 knockout preserves clonogenic potential after BBR/NC‐SAPs treatment. (C) Analysis of DNA synthesis by EdU incorporation assay utilizing flow cytometry, demonstrating that NR2F2 knockout preserves cell proliferation potential after BBR/NC‐SAPs treatment. (D) Assessment of mitochondrial membrane potential (ΔΨm) via JC‐1 or similar dye, denoting that NR2F2 deletion prevents membrane depolarization triggered by BBR/NC‐SAPs. (E) Quantification of intracellular Fe 2+ showing blocked iron accumulation in NR2F2‐deficient cells upon BBR/NC‐SAPs treatment. (F) Lipid ROS levels measured by flow cytometry demonstrating that BBR/NC‐SAPs fail to elevate lipid peroxidation in NR2F2‐knockout cells. Ferroptosis‐related protein levels measured by western blot showing that BBR/NC‐SAPs fail to elevate lipid peroxidation in NR2F2‐knockout cells (G, 8226 and 8226‐BTZR; H, KMS‐11 and KMS‐11‐BTZR).

    Article Snippet: The mitochondrial membrane potential (ΔΨm) was assessed utilizing the fluorescent probe JC‐1 (MCE, USA) according to the manufacturer's protocol.

    Techniques: Knock-Out, Control, DNA Synthesis, Flow Cytometry, Membrane, Western Blot

    Gpat4 deficiency drives tumor-cell innate immune activation through the mtDNA-cGAS-dependent axis independently of the canonical cataly tic motif. (A) Schematic of glycerolipid and ether-lipid biosynthetic pathways highlighting GPAT4 and related enzymes used for comparison. (B) qPCR analysis of Ifnb1 , Ifi44 and Cxcl10 after depletion of the indicated lipid-metabolic regulators. (C) Domain organization of wild-type GPAT4 and the HXXXXD catalytic-motif mutant used for rescue experiments. (D) qPCR analysis of interferon-responsive genes in Gpat4 -depleted cells reconstituted with empty vector, wild-type GPAT4 or catalytic-mutant GPAT4 to determine whether the immune phenotype depends on the canonical catalytic motif. (E) qPCR analysis of Ifi44 and Ifit1 in control and Gpat4 -depleted cells treated with vehicle or the cGAS inhibitor RU521 to test cGAS dependence. (F) Measurements of mitochondrial membrane potential and reactive oxygen species in control and Gpat4 -depleted cells. The corresponding gating workflow for JC-1 and H 2 DCFDA analysis is shown in (G, H) Representative transmission electron micrographs showing mitochondrial ultrastructure in 4T1 control (gNC) and Gpat4 -deficient (g Gpat4 ) cells. Red arrows indicate mitochondria. White boxes in (G) denote the regions enlarged in (H). Compared with control cells, Gpat4 -deficient cells display evident mitochondrial abnormalities, including altered shape and disorganization of cristae. Scale bars: 1 μm (G) and 0.5 μm (H). (I) Quantification of cytosolic mtDNA amplicons shown in the panel, including mtCytb (1), mtCytb (2), mtDloop1, mtDloop2, mtDloop3 and mtND6, together with nuclear DNA Tert as a contamination control, in cytosolic fractions prepared from control and Gpat4 -depleted cells. Bars denote mean ± s.e.m., P values are indicated in the respective panels, and exact P values are shown where provided and otherwise significance is denoted as ns or by asterisks. The statistical methods are described in the Materials and methods section. ns, not significant; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.000 1.

    Journal: Cell Insight

    Article Title: GPAT4 regulates antitumor immune response through activating the mtDNA-cGAS axis in cancer cells

    doi: 10.1016/j.cellin.2026.100343

    Figure Lengend Snippet: Gpat4 deficiency drives tumor-cell innate immune activation through the mtDNA-cGAS-dependent axis independently of the canonical cataly tic motif. (A) Schematic of glycerolipid and ether-lipid biosynthetic pathways highlighting GPAT4 and related enzymes used for comparison. (B) qPCR analysis of Ifnb1 , Ifi44 and Cxcl10 after depletion of the indicated lipid-metabolic regulators. (C) Domain organization of wild-type GPAT4 and the HXXXXD catalytic-motif mutant used for rescue experiments. (D) qPCR analysis of interferon-responsive genes in Gpat4 -depleted cells reconstituted with empty vector, wild-type GPAT4 or catalytic-mutant GPAT4 to determine whether the immune phenotype depends on the canonical catalytic motif. (E) qPCR analysis of Ifi44 and Ifit1 in control and Gpat4 -depleted cells treated with vehicle or the cGAS inhibitor RU521 to test cGAS dependence. (F) Measurements of mitochondrial membrane potential and reactive oxygen species in control and Gpat4 -depleted cells. The corresponding gating workflow for JC-1 and H 2 DCFDA analysis is shown in (G, H) Representative transmission electron micrographs showing mitochondrial ultrastructure in 4T1 control (gNC) and Gpat4 -deficient (g Gpat4 ) cells. Red arrows indicate mitochondria. White boxes in (G) denote the regions enlarged in (H). Compared with control cells, Gpat4 -deficient cells display evident mitochondrial abnormalities, including altered shape and disorganization of cristae. Scale bars: 1 μm (G) and 0.5 μm (H). (I) Quantification of cytosolic mtDNA amplicons shown in the panel, including mtCytb (1), mtCytb (2), mtDloop1, mtDloop2, mtDloop3 and mtND6, together with nuclear DNA Tert as a contamination control, in cytosolic fractions prepared from control and Gpat4 -depleted cells. Bars denote mean ± s.e.m., P values are indicated in the respective panels, and exact P values are shown where provided and otherwise significance is denoted as ns or by asterisks. The statistical methods are described in the Materials and methods section. ns, not significant; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.000 1.

    Article Snippet: To assess mitochondrial stress, intracellular reactive oxygen species were measured using H 2 DCFDA (Solarbio), and mitochondrial membrane potential was measured using JC-1 (MCE) by flow cytometry.

    Techniques: Activation Assay, Comparison, Mutagenesis, Plasmid Preparation, Control, Membrane, Transmission Assay

    IPA protects mBMSCs against H 2 O 2 -induced apoptotic injury. (A) Effects of IPA on mBMSC viability over 1, 2, and 3 days, as determined by the CCK-8 assay. (B) Effects of IPA pretreatment on mBMSC viability following H 2 O 2 exposure for 12, 24, and 48 h, as determined by the CCK-8 assay. (C) Live/dead staining of mBMSCs on day 1 using propidium iodide (dead cells) and Calcein-AM (live cells). (D) Quantification of the dead-cell ratio based on live/dead staining. (E) Mitochondrial membrane potential of H 2 O 2 -treated mBMSCs with or without IPA treatment for 1 day, assessed by JC-1 staining. (F) Quantification of the red/green fluorescence ratio from JC-1 staining. All experiments were repeated at least three times. Data are presented as the mean ± SD. ** P<0.01 compared with the control group. IPA, indole-3-propionic acid; mBMSCs, mouse bone marrow stromal cells; CCK-8, Cell Counting Kit-8; ns, not significant.

    Journal: International Journal of Molecular Medicine

    Article Title: Microbiota-derived indole-3-propionic acid reprograms bone marrow stem cell fate via PPARγ suppression to rescue osteoporosis

    doi: 10.3892/ijmm.2026.5879

    Figure Lengend Snippet: IPA protects mBMSCs against H 2 O 2 -induced apoptotic injury. (A) Effects of IPA on mBMSC viability over 1, 2, and 3 days, as determined by the CCK-8 assay. (B) Effects of IPA pretreatment on mBMSC viability following H 2 O 2 exposure for 12, 24, and 48 h, as determined by the CCK-8 assay. (C) Live/dead staining of mBMSCs on day 1 using propidium iodide (dead cells) and Calcein-AM (live cells). (D) Quantification of the dead-cell ratio based on live/dead staining. (E) Mitochondrial membrane potential of H 2 O 2 -treated mBMSCs with or without IPA treatment for 1 day, assessed by JC-1 staining. (F) Quantification of the red/green fluorescence ratio from JC-1 staining. All experiments were repeated at least three times. Data are presented as the mean ± SD. ** P<0.01 compared with the control group. IPA, indole-3-propionic acid; mBMSCs, mouse bone marrow stromal cells; CCK-8, Cell Counting Kit-8; ns, not significant.

    Article Snippet: MMP was assessed using a JC-1 assay kit (MedChemExpress).

    Techniques: CCK-8 Assay, Staining, Membrane, Fluorescence, Control, Cell Counting

    Res-PD-L1@nmEVs Restores Mitochondrial Homeostasis and Improves Energy Metabolism BEAS-2B cells were pretreated with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs followed by H/R stimulation for subsequent analysis. (A) Representative immunofluorescence images showing the expression and localization of PINK1 (green) and the mitochondrial marker TOMM20 (red), indicating activation of mitophagy. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (B) Quantitative analysis of PINK1 fluorescence intensity. (C) Expression and localization of autophagy-related proteins LC3B and Beclin-1 detected by immunofluorescence. (D-E) Quantitative analysis of LC3B (D) and Beclin-1 (E) fluorescence intensity. (F) Mitochondrial membrane potential assessed by JC-1 staining and flow cytometry. (G) Oxygen consumption rate (OCR) profiles of lung epithelial cells under different treatments. (H-K) Key mitochondrial respiration parameters: basal respiration (H), maximal respiration (I), proton leak (J), and ATP production (K). (L) Representative confocal microscopy images of mitochondria stained with MitoTracker (green) and lysosomes stained with LysoTracker (red), demonstrating mitochondrial-lysosomal colocalization. Scale bar: 5 μm ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.

    Journal: Bioactive Materials

    Article Title: Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia–reperfusion lung injury and pneumonia

    doi: 10.1016/j.bioactmat.2026.03.024

    Figure Lengend Snippet: Res-PD-L1@nmEVs Restores Mitochondrial Homeostasis and Improves Energy Metabolism BEAS-2B cells were pretreated with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs followed by H/R stimulation for subsequent analysis. (A) Representative immunofluorescence images showing the expression and localization of PINK1 (green) and the mitochondrial marker TOMM20 (red), indicating activation of mitophagy. Nuclei were stained with DAPI (blue). Scale bar: 50 μm. (B) Quantitative analysis of PINK1 fluorescence intensity. (C) Expression and localization of autophagy-related proteins LC3B and Beclin-1 detected by immunofluorescence. (D-E) Quantitative analysis of LC3B (D) and Beclin-1 (E) fluorescence intensity. (F) Mitochondrial membrane potential assessed by JC-1 staining and flow cytometry. (G) Oxygen consumption rate (OCR) profiles of lung epithelial cells under different treatments. (H-K) Key mitochondrial respiration parameters: basal respiration (H), maximal respiration (I), proton leak (J), and ATP production (K). (L) Representative confocal microscopy images of mitochondria stained with MitoTracker (green) and lysosomes stained with LysoTracker (red), demonstrating mitochondrial-lysosomal colocalization. Scale bar: 5 μm ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.

    Article Snippet: Changes in mitochondrial membrane potential were assessed by JC-1 staining (C2003S, Beyotime).

    Techniques: Immunofluorescence, Expressing, Marker, Activation Assay, Staining, Fluorescence, Membrane, Flow Cytometry, Confocal Microscopy, Control

    Piroxicam alleviated mitochondrial oxidative stress and restored the mitochondrial function of HG-induced HaCaT cells. After 24 h of induction with HG (60 mM), HaCaT cells were treated with piroxicam (0, 1.2, 3.7, 11, 33, 100 nM) for 24 h. (A) The level of ROS within mitochondria was assessed using MitoSOX staining, and red fluorescence indicated mitochondrial superoxide (scale bar = 50 μm). (B) HaCaT cells were stained with JC-1 dye. Red fluorescence (JC-1 aggregates) indicated healthy mitochondria with a high MMP, while green fluorescence (JC-1 monomers) indicated mitochondrial membrane depolarization (scale bar = 50 μm). (C) The expression of mitochondrial respiratory chain complex proteins, including ATP5A1 (complex V), MT-CO2 (complex IV), UQCRC1 (complex III), SDHB (complex II), and NDUFB8 (complex I), of HaCaT cells was determined by Western blotting. (D) Quantitative analysis of protein levels of ATP5A1, MT-CO2, UQCRC1, SDHB, and NDUFB8 was performed. (E) The expression of mitochondrial dynamics-related proteins, including DRP1, MFN1, MFN2, and OPA1, was measured using Western blotting. (F) Quantitative analysis of protein levels of DRP1, MFN1, MFN2, and OPA1 was performed. (G) HaCaT cells were stained with MitoTracker and observed using a confocal microscope (scale bar = 10 μm). All data were presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 compared to the 0 nM group ( n = 3). Abbreviations: HG, high glucose; SD, standard deviation; ROS, reactive oxygen species; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide; MMP, mitochondrial membrane potential; ATP5A1, ATP synthase F1 subunit alpha; MT-CO2, mitochondrial-encoded cytochrome c oxidase 2; UQCRC1, ubiquinol-cytochrome c reductase core protein 1; SDHB, succinate dehydrogenase complex iron-sulfur subunit B; NDUFB8, NADH: ubiquinone oxidoreductase subunit B8; DRP1, dynamin-related protein 1; MFN1, mitofusin 1; MFN2, mitofusin 2; OPA1, optic atrophy 1.

    Journal: Frontiers in Pharmacology

    Article Title: Piroxicam accelerates diabetic foot ulcer healing via ERα-dependent mitochondrial protection and oxidative stress relief

    doi: 10.3389/fphar.2026.1834818

    Figure Lengend Snippet: Piroxicam alleviated mitochondrial oxidative stress and restored the mitochondrial function of HG-induced HaCaT cells. After 24 h of induction with HG (60 mM), HaCaT cells were treated with piroxicam (0, 1.2, 3.7, 11, 33, 100 nM) for 24 h. (A) The level of ROS within mitochondria was assessed using MitoSOX staining, and red fluorescence indicated mitochondrial superoxide (scale bar = 50 μm). (B) HaCaT cells were stained with JC-1 dye. Red fluorescence (JC-1 aggregates) indicated healthy mitochondria with a high MMP, while green fluorescence (JC-1 monomers) indicated mitochondrial membrane depolarization (scale bar = 50 μm). (C) The expression of mitochondrial respiratory chain complex proteins, including ATP5A1 (complex V), MT-CO2 (complex IV), UQCRC1 (complex III), SDHB (complex II), and NDUFB8 (complex I), of HaCaT cells was determined by Western blotting. (D) Quantitative analysis of protein levels of ATP5A1, MT-CO2, UQCRC1, SDHB, and NDUFB8 was performed. (E) The expression of mitochondrial dynamics-related proteins, including DRP1, MFN1, MFN2, and OPA1, was measured using Western blotting. (F) Quantitative analysis of protein levels of DRP1, MFN1, MFN2, and OPA1 was performed. (G) HaCaT cells were stained with MitoTracker and observed using a confocal microscope (scale bar = 10 μm). All data were presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 compared to the 0 nM group ( n = 3). Abbreviations: HG, high glucose; SD, standard deviation; ROS, reactive oxygen species; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide; MMP, mitochondrial membrane potential; ATP5A1, ATP synthase F1 subunit alpha; MT-CO2, mitochondrial-encoded cytochrome c oxidase 2; UQCRC1, ubiquinol-cytochrome c reductase core protein 1; SDHB, succinate dehydrogenase complex iron-sulfur subunit B; NDUFB8, NADH: ubiquinone oxidoreductase subunit B8; DRP1, dynamin-related protein 1; MFN1, mitofusin 1; MFN2, mitofusin 2; OPA1, optic atrophy 1.

    Article Snippet: MMP was detected using a 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) staining probe (MedChemExpress, Monmouth Junction, NJ, United States) following the manufacturer’s instructions.

    Techniques: Staining, Fluorescence, Membrane, Expressing, Western Blot, Microscopy, Standard Deviation